Ordinary Shares SEC Reporting - Current
Verified Company Profile 1/12/2017
Contact Info
  • Suite 1128
  • 789 West Pender Street
  • Vancouver, BC V6C 1H2
  • Canada

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Dec 31, 2016 20-F
CIK 0001355736
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: British Columbia, Canada
Year of Inc. 2000
Employees Not Available
Company Officers/Contacts
Arun Nayyar CEO
Anna Truman Controller
Jim O'Connell Finance & Controlling
Company Directors
Eugene Beukman
David Hall
Bob Rai
Service Providers
Accounting/Auditing Firm
Adam Kim Ltd.
2001 - 1177 West Hasting Street
V6E 2K3
Securities Counsel
Sangra Moller LLP
1000 Cathedral Place
925 West Georgia Street
Vancouver, BC, V6C 3L2
Investor Relations Firm

Not Available
Company History
  • Formerly=Nuva Pharmaceuticals Inc. until 8-2014
  • Formerly=Alda Pharmaceuticals Corp. until 7-2013
NUVPF Security Details
Share Structure
Market Value1 $2,550,220 a/o Jun 26, 2017
Authorized Shares 60,005,225 a/o Oct 31, 2016
Outstanding Shares 15,001,297 a/o Dec 31, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value No Par Value
Shareholders of Record 2,200 a/o May 25, 2017
Non US Stock Exchange Listing
VANC - TSX Venture Exchange - Qualified
Short Selling Data
Short Interest 798 (0%)
Mar 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security